WO2019058904A1 - Antiperspirant composition - Google Patents

Antiperspirant composition Download PDF

Info

Publication number
WO2019058904A1
WO2019058904A1 PCT/JP2018/031834 JP2018031834W WO2019058904A1 WO 2019058904 A1 WO2019058904 A1 WO 2019058904A1 JP 2018031834 W JP2018031834 W JP 2018031834W WO 2019058904 A1 WO2019058904 A1 WO 2019058904A1
Authority
WO
WIPO (PCT)
Prior art keywords
component
mass
content
skin
antiperspirant
Prior art date
Application number
PCT/JP2018/031834
Other languages
French (fr)
Japanese (ja)
Inventor
公樹 友松
Original Assignee
ライオン株式会社
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP2018044089A external-priority patent/JP7049868B2/en
Application filed by ライオン株式会社 filed Critical ライオン株式会社
Publication of WO2019058904A1 publication Critical patent/WO2019058904A1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A61K8/26Aluminium; Compounds thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A61K8/28Zirconium; Compounds thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/34Alcohols
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/37Esters of carboxylic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/39Derivatives containing from 2 to 10 oxyalkylene groups
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/41Amines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/84Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
    • A61K8/86Polyethers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/84Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
    • A61K8/89Polysiloxanes
    • A61K8/891Polysiloxanes saturated, e.g. dimethicone, phenyl trimethicone, C24-C28 methicone or stearyl dimethicone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q15/00Anti-perspirants or body deodorants

Definitions

  • the present invention relates to antiperspirant compositions.
  • Antiperspirant ingredients such as aluminum salts and bactericidal ingredients are used in roll-on type and lotion type antiperspirants that use water as a solvent. Furthermore, when adding an oil-based component for the purpose of giving a feeling etc., it is known that emulsifiers, such as nonionic surfactant, are used (for example, refer to patent documents 1). However, after applying such an antiperspirant to the skin, the solvent water volatilizes to cause the aluminum salt to be whitened on the skin, achieving both the antiperspirant effect and the absence of white remnant on the skin. There was a problem that it was difficult to do.
  • these components work synergistically, and after application of the antiperspirant composition, the skin becomes sticky, skin firmness, and skin It has been found that there is no irritation to the skin, the deodorizing effect and the stability of the preparation are excellent, and the white remnant of the skin can be suppressed while maintaining the antiperspirant effect.
  • the present invention is based on the findings by the present inventors, and means for solving the problems are as follows.
  • A at least one antiperspirant component selected from an aluminum compound, a zirconium compound, and a complex thereof
  • B a bactericidal component
  • C at least one selected from triglyceride (C1), fatty acid isoamyl (C2), and linear alkyl-modified silicone (C3);
  • D2 polyoxyethylene alkyl ether having an average added mole number of ethylene oxide of 10 or more and 30 or less
  • E containing water
  • the content of the component (E) is 65% by mass to 90% by mass.
  • the component (C1) and the component (C2) are contained, It is an antiperspirant composition as described in said ⁇ 1> whose mass ratio (C1 / C2) of content of said (C1) component and content of said (C2) component is 0.5-2 .
  • ⁇ 3> The antiperspirant composition according to any one of ⁇ 1> to ⁇ 2>, wherein the component (A) is chlorhydroxyaluminum.
  • ⁇ 4> The antiperspirant according to any one of ⁇ 1> to ⁇ 3>, wherein the component (B) is at least one selected from cetyl pyridinium chloride, benzalkonium chloride, and isopropyl methyl phenol It is a composition.
  • the component (C1) is at least one selected from tri (caprylic acid / capric acid) glyceryl and caprylic acid triglyceride
  • the component (C2) is at least one selected from isoamyl laurate, isoamyl caprate, and coconut oil fatty acid isoamyl
  • the antiperspirant composition according to any one of ⁇ 1> to ⁇ 4>, wherein the component (C3) is at least one selected from cetyl dimethicone, stearyl dimethicone, and caprylyl methicone.
  • the content of the component (A) is 7% by mass to 20% by mass
  • the content of the component (B) is 0.1% by mass to 0.3% by mass
  • the content of the component (C1) is 0.8% by mass to 2% by mass
  • the content of the component (C2) is 0.8% by mass to 2% by mass
  • the content of the component (C3) is 1% by mass to 3% by mass
  • the content of the component (D1) is 1.5% by mass to 3.5% by mass
  • the content of the component (D2) is 1.5% by mass to 2.5% by mass
  • the antiperspirant composition according to any one of ⁇ 1> to ⁇ 5>, wherein a content of the component (E) is 70% by mass to 85% by mass.
  • the mass ratio (D1 / D2) of the content of the ⁇ 7> component (D1) to the content of the component (D2) is 0.7 to 2.0, and the mass ratio of ⁇ 1> to ⁇ 6> It is an antiperspirant composition in any one. It is an antiperspirant composition in any one of said ⁇ 1> to ⁇ 7> which is either ⁇ 8> roll-on type and a lotion type.
  • the above-mentioned various problems in the prior art can be solved and the above object can be achieved, and there is no stickiness of the skin after application of the antiperspirant composition, no feeling of skin tightness and skin irritation, deodorizing effect And while being excellent in the stability of a formulation, the antiperspirant composition which can suppress the white remnant of skin can be provided, maintaining an antiperspirant effect.
  • the antiperspirant composition of the present invention is selected from (A) antiperspirant component, (B) bactericidal component, (C) triglyceride (C1), fatty acid isoamyl (C2), and linear alkyl-modified silicone (C3) (D1) polyoxyethylene alkyl ether having an average addition mole number of 2 or more and 8 or less, (D2) polyoxyethylene alkyl ether having an average addition mole number of 10 to 30 of (D1) ethylene oxide, And (E) contains water, and further contains other components as required.
  • the antiperspirant component of the component (A) is at least one selected from an aluminum compound, a zirconium compound, and a complex thereof.
  • the antiperspirant component of the component (A) is contained to impart an antiperspirant effect.
  • Examples of the aluminum compound, zirconium compound, and complexes thereof include aluminum chloride, aluminum sulfate, aluminum potassium sulfate, aluminum acetate, chlorohydroxyaluminum, allantoin chlorohydroxyaluminum, chlorohydroxyaluminum / propylene glycol complex, chlorohydroxyaluminum / Examples thereof include zirconium and glycine complexes. These may be used alone or in combination of two or more. Among these, chlorohydroxyaluminum and chlorohydroxyaluminum / propylene glycol complex are preferable, and chlorohydroxyaluminum is more preferable, in that the antiperspirant effect is more excellent.
  • an antiperspirant component of said (A) component There is no restriction
  • the commercially available products include chlorhydroxyaluminum (trade name: chlorhydroxyaluminum, manufactured by Takaki Chemical Co., Ltd.), chlorhydroxyaluminum / propylene glycol complex (trade name: REHYDROL II, manufactured by Summit Reheis), and aluminum potassium sulfate (Trade name: potassium alum, manufactured by Daimei Chemical Industries, Ltd.), chlorhydroxyaluminum / zirconium-glycine complex (trade name: Reach AZO-956G, manufactured by Summit Reheis), and the like.
  • the content of the antiperspirant component of the component (A) is 5% by mass with respect to the total amount of the antiperspirant composition from the viewpoint of antiperspirant effect, lack of skin firmness and non-stickiness of the skin 25% by mass is preferable, and 7% by mass to 20% by mass is more preferable.
  • the content is less than 5% by mass, the antiperspirant effect may be insufficient, and when it exceeds 25% by mass, the feeling of skin firmness and the feeling of stickiness of the skin become insufficient. Sometimes.
  • the sterilizing component of the component (B) is contained to impart a deodorizing effect.
  • Examples of the sterilizing component of the component (B) include cetyl pyridinium chloride, benzalkonium chloride, isopropyl methyl phenol and the like. These may be used alone or in combination of two or more. Among these, cetyl pyridinium chloride and benzalkonium chloride are preferable in terms of the deodorizing effect.
  • the sterilizing component of the component (B) for example, cetyl pyridinium chloride (trade name: cetyl pyridinium chloride, manufactured by Wako Pure Chemical Industries, Ltd.), benzalkonium chloride (trade name: trizone solution, Yamada Pharmaceutical Co., Ltd.) And Isopropylmethylphenol (trade name: isopropylmethylphenol, manufactured by Osaka Kasei Co., Ltd.).
  • cetyl pyridinium chloride trade name: cetyl pyridinium chloride, manufactured by Wako Pure Chemical Industries, Ltd.
  • benzalkonium chloride trade name: trizone solution, Yamada Pharmaceutical Co., Ltd.
  • Isopropylmethylphenol trade name: isopropylmethylphenol, manufactured by Osaka Kasei Co., Ltd.
  • the content of the component (B) is preferably 0.05% by mass to 0.5% by mass, based on the total amount of the antiperspirant composition, from the viewpoint of deodorizing effect and no irritation to the skin. 1% by mass to 0.3% by mass is more preferable. If the content is less than 0.05% by mass, the deodorizing effect may be insufficient. If the content is more than 0.5% by mass, the lack of skin irritation may be insufficient.
  • Component (C) At least one selected from triglyceride (C1), fatty acid isoamyl (C2), and linear alkyl-modified silicone (C3)> Component (C): at least one selected from triglyceride (C1), fatty acid isoamyl (C2), and linear alkyl-modified silicone (C3) is included to impart whiteness of the skin Ru. It is preferable that the said (C) component uses together the said (C1) component and the said (C2) component.
  • Examples of the triglyceride of the component (C1) include glyceryl tri (caprylic acid ⁇ capric acid), caprylic acid triglyceride and the like. These may be used alone or in combination of two or more. Among these, tri (caprylic acid / capric acid) glyceryl is preferable from the viewpoint of no whitening of the skin.
  • Examples of the fatty acid isoamyl of the component (C2) include isoamyl laurate, isoamyl caprylate, isoamyl caprate, coconut oil fatty acid isoamyl and the like. These may be used alone or in combination of two or more. Among these, isoamyl laurate, isoamyl caprate and coconut oil fatty acid isoamyl are preferable, and isoamyl laurate is more preferable, from the viewpoint of no whitening of the skin.
  • linear alkyl-modified silicone of the component (C3) examples include cetyl dimethicone, stearyl dimethicone and caprylyl methicone. These may be used alone or in combination of two or more. Among these, cetyl dimethicone is preferable from the viewpoint of no whitening of the skin.
  • Examples of commercially available products of the component (C1) include glyceryl tri (caprylic acid and capric acid) (trade name: CRODAMOL GTCC, manufactured by Croda Japan KK), caprylic acid triglyceride (trade name: tricaprylin, Tokyo Chemical Industry Co., Ltd.) Company-made).
  • Examples of commercial products of the component (C2) include isoamyl laurate (trade name: isoamyl laurate, manufactured by Tokyo Chemical Industry Co., Ltd.), and isoamyl caprylate (trade name: isoamyl caprylate, manufactured by Tokyo Chemical Industry Co., Ltd.) And isoamyl caprylate (trade name: isoamyl caprate, manufactured by Tokyo Chemical Industry Co., Ltd.), coconut oil fatty acid isoamyl (trade name: TEGOSOFT AC, manufactured by Evonik Nutrition & Care GmbH), and the like.
  • Examples of commercial products of the component (C3) include cetyl dimethicone (trade name: ABIL WAX 9801, manufactured by Evonik Nutrition & Care GmbH), stearyl dimethicone (trade name: ABIL WAX 9800, manufactured by Evonik Nutrition & Care GmbH) And caprylyl methicone (trade name: FZ-3196, manufactured by Toray Dow Corning Co., Ltd.).
  • the content of the component (C1) is 0.5% by mass to 3% with respect to the total amount of the antiperspirant composition from the viewpoint of no whitening of the skin, stability of the preparation, and no stickiness of the skin. % By mass is preferable, and 0.8% by mass to 2% by mass is more preferable. When the content is less than 0.5% by mass, the lack of whiteness of the skin may be insufficient, and when it exceeds 3% by mass, the stability of the preparation and the non-stickiness of the skin may not be sufficient. It may be enough.
  • the content of the component (C2) is 0.5% by mass to 3% with respect to the total amount of the antiperspirant composition from the viewpoint of no whitening of the skin, stability of the preparation, and no stickiness of the skin. % By mass is preferable, and 0.8% by mass to 2% by mass is more preferable. When the content is less than 0.5% by mass, the lack of whiteness of the skin may be insufficient, and when it exceeds 3% by mass, the stability of the preparation and the non-stickiness of the skin may not be sufficient. It may be enough.
  • the content of the component (C3) is preferably 0.5% by mass to 5% by mass, based on the total amount of the antiperspirant composition, from the viewpoint of no whitening of the skin and the stability of the preparation. % To 3% by mass is more preferable. When the content is less than 0.5% by mass, the lack of whiteness of the skin may be insufficient, and when it exceeds 5% by mass, the stability of the preparation may be insufficient.
  • the mass ratio (C1 / C2) of the content of the component (C1) to the content of the component (C2) is 0.3 to 3 in view of the stability of the preparation and no stickiness of the skin. 6 is preferable, and 0.5 to 2 is more preferable. When the mass ratio is less than 0.3 or more than 3.6, the stability of the preparation and the tackiness of the skin may be insufficient.
  • the polyoxyethylene alkyl ether of the component (D) has an average addition mole number of (D1) ethylene oxide of 2 or more and 8 or less, and an average addition mole number of (D2) ethylene oxide of 10 or more and 30.
  • the following polyoxyethylene alkyl ether is contained.
  • the component (D) is included to improve the stability of the preparation.
  • the average addition mole number of the polyoxyethylene alkyl ether having an average addition mole number of 2 to 8 of ethylene oxide of the component (D1) is preferably 2 to less than 5 from the viewpoint of the stability of the preparation. When the average addition mole number exceeds 8, the stability of the preparation may be insufficient. There is no commercially available product available for polyoxyethylene alkyl ethers in which the average addition mole number of ethylene oxide is less than 2.
  • the average addition mole number of the ethylene oxide in the component (D2) is 10 to 30 and the average addition mole number of the polyoxyethylene alkyl ether is 10 to 30 from the viewpoint of stability of the preparation and no stickiness of the skin.
  • the following are preferred.
  • the average addition mole number is less than 10, the stability of the preparation may be insufficient, and when the average addition mole number exceeds 30, the stability of the preparation and the non-greasy skin are insufficient. It can be
  • the polyoxyethylene alkyl ether having an average addition mole number of ethylene oxide of 2 to 8 as the component (D1) is not particularly limited and may be appropriately selected according to the purpose.
  • the average addition of ethylene oxide is The polyoxyethylene stearyl ether etc. whose number-of-moles are 2 or more and 8 or less are mentioned.
  • polyoxyethylene alkylether in which the average added mole number of the ethylene oxide of the said (D2) component is 10-30, can be selected suitably according to the objective,
  • the average addition of ethylene oxide The polyoxyethylene stearyl ether etc. whose mole number is ten or more and 30 or less are mentioned.
  • Steareth-2 (trade name: EMALEX 602) and Steareth-3 (trade name: EMALEX 603)
  • Steareth-5 trade name: EMALEX 605
  • Steareth-8 (trade name: EMALEX 608) (all manufactured by Nippon Emulsion Co., Ltd.), and the like.
  • Steareth-11 (trade name: EMALEX 611) and Steareth-15, wherein the average addition mole number of ethylene oxide is 11, 15, 16, 20, 25 and 30, respectively.
  • EMALEX 615 (trade name: EMALEX 615), Steareth-16 (trade name: EMALEX 616), Steareth -20 (trade name: EMALEX 620), Steareth-25 (trade name: EMALEX 625), Steareth-30 (trade name: EMALEX 630) (all of which are Nippon Emulsion Co., Ltd.) and the like.
  • the content of the component (D1) is preferably 1% by mass to 5% by mass, and preferably 1.5% by mass, with respect to the total amount of the antiperspirant composition, in terms of stability of the preparation and no stickiness of the skin. % To 3.5% by mass is more preferable. If the content is less than 1% by mass, the stability of the preparation may be insufficient. If it is more than 5% by mass, the tackiness of the skin may be insufficient.
  • the content of the component (D2) is preferably 1% by mass to 3% by mass, and preferably 1.5% by mass, with respect to the total amount of the antiperspirant composition, from the viewpoint of stability of the preparation and tackiness of the skin. % To 2.5% by mass is more preferable. If the content is less than 1% by mass, the stability of the preparation may be insufficient, and if it is more than 3% by mass, the skin tackiness may be insufficient.
  • the mass ratio (D1 / D2) of the content of the component (D1) to the content of the component (D2) is preferably 0.4 to 4.0 from the viewpoint of the stability of the preparation, and 0. 7 to 2.0 is more preferable. If the mass ratio is less than 0.4 or more than 4.0, the stability of the preparation may be insufficient.
  • the water of the component (E) is contained to impart stability of the preparation.
  • the content of water of the component (E) is 65% by mass to 90% by mass with respect to the total amount of the antiperspirant composition from the viewpoint of stability of the preparation and no stickiness of the skin, 70% by mass % To 85% by mass is preferable.
  • the content is less than 65% by mass, the stability of the preparation may be insufficient, and when it is more than 90% by mass, the smoothness of the skin may be insufficient.
  • the content of water of the component (E) is the total content including the water carried from these components when the components (A) to (D) and the other components are blended. .
  • the antiperspirant composition of the present invention is usually added to the antiperspirant composition according to the dosage form as long as the effects of the present invention are not impaired.
  • Other ingredients can be added.
  • limiting in particular as said other component According to the objective, it can select suitably, For example, a fats-and-oils compound, a wax compound, a silicone compound, hydrocarbon oil, a higher fatty acid, a higher alcohol, except the said (D) component
  • limiting in particular as content of said other component According to the objective, it can select suitably in the range which does not prevent the
  • the pH of the antiperspirant composition at 25 ° C. is preferably 3 to 4.5 from the viewpoint of antiperspirant effect, no irritation to the skin and stability of the preparation. If the pH is less than 3, the antiperspirant effect and the lack of skin irritation may be insufficient, and if it exceeds 4.5, the stability of the preparation may be insufficient.
  • a viscosity of the said antiperspirant composition there is no restriction
  • the viscosity is measured, for example, at 25 ° C. using a BL viscometer at 25 ° C. It can be measured at 60 rpm for 1 minute using 1 to 4 rotors.
  • an emulsion is obtained by mixing an oil phase containing the component (C) and the component (D) with an aqueous phase containing the component (E) under the temperature condition equal to or higher than the melting point of the component (D) And then, if necessary, by adding and mixing the (A) component and the (B) component to the obtained emulsion.
  • an apparatus which prepares the said antiperspirant composition there is no restriction
  • the components (A) to (E) and the other components may be used alone or as a mixture containing two or more components. You may use it in the state of.
  • a dosage form of the said antiperspirant composition For example, semi-solid type, gel-like type, liquid type etc. are mentioned. Among them, gel-type and liquid-type are preferable in that they are applied to the skin in a state dissolved in water, which is effective for exhibiting the effect, can be applied in high adhesion, and can exhibit high antiperspirant effect. Type is more preferred.
  • As said semi-solid type a cream type etc. are mentioned, for example.
  • a gel-like type, gel type etc. are mentioned, for example.
  • a roll on type, a lotion type, a mist type etc. are mentioned, for example. Among these, roll-on type and lotion type are preferable in terms of antiperspirant effect.
  • the antiperspirant product comprises the antiperspirant composition and a coating ball, and comprises a roll-on container filled with the antiperspirant composition.
  • the roll-on type preparation is contained in a known roll-on container, and the antiperspirant composition is attached to the coating ball held in a holder rotatably with a part thereof exposed in the roll-on container,
  • the application ball can be attached to the skin and applied at the time of use.
  • a gel preparation which is filled with the antiperspirant composition in a bottle container and applied as it is using a container; a gel preparation which is applied using a fingertip or a hand, and a lotion preparation can also be suitably used.
  • the container examples include a roll-on container, a bottle container for gel, a bottle container for lotion, and a trigger type spray container for mist.
  • roll-on containers are preferable in terms of antiperspirant effect.
  • the roll-on container can be suitably used in that the antiperspirant composition can be applied in close contact with the skin and the antiperspirant effect can be exhibited.
  • the roll-on container is not particularly limited as long as it can be filled with the antiperspirant composition, and can be appropriately selected according to the purpose. For example, those described in JP-A-2005-186997 and the like Can be mentioned.
  • a bottle material: HDPE natural, full filling internal volume: about 56 mL, body diameter: about 33 mm, height: about 87 mm, made by Yoshino Kogyo Co., Ltd.
  • ring material: LLDPE natural, Outer diameter: about 26 mm, height: about 18 mm, manufactured by Yoshino Industry Co., Ltd.
  • ball material: PP white, diameter: about 20 mm, manufactured by Yoshino Industrial Co., Ltd.
  • a bottle for example, a bottle (trade name: TOM III-50, material: HDPE natural, full filling volume: about 34 mL, body diameter: about 42 mm ⁇ 29 mm (oval), height: about 88 mm, Takemoto Container Co., Ltd.), inside plug (product name: TO cap nozzle A, material: PE natural, outer diameter: about 12 mm, height: about 13 mm, product made by Takemoto Container Co., Ltd.), cap (product name: TOM III cap, Material: PP white, outer diameter: about 37 mm ⁇ 25 mm (oval), height: about 24 mm, manufactured by Takemoto Container Co., Ltd.) or the like can be used.
  • TOM III-50 material: HDPE natural, full filling volume: about 34 mL, body diameter: about 42 mm ⁇ 29 mm (oval), height: about 88 mm, Takemoto Container Co., Ltd.
  • inside plug product name: TO cap nozzle A, material: PE natural, outer diameter: about 12 mm, height: about 13
  • the antiperspirant composition of the present invention is excellent in the deodorizing effect and the stability of the preparation as well as the antiperspirant effect, since it is not sticky after the application of the antiperspirant composition, there is no skin firmness and skin irritation.
  • whiteness of the skin can be suppressed while maintaining it, for example, it can be applied to cosmetics, medicines, quasi-drugs, etc., and it can be used as an antiperspirant, deodorant, antiperspirant, deodorant and deodorant. It is suitably available.
  • Examples 1 to 57 and Comparative Examples 1 to 10 The antiperspirant compositions of Examples 1 to 57 and Comparative Examples 1 to 10, which have the compositions shown in Tables 1 to 10 below, were prepared by an ordinary method. 40 mL of each obtained antiperspirant composition was filled in a roll-on container of the following specification to make a roll-on type antiperspirant composition.
  • the antiperspirant effect for each of the roll-on type antiperspirant compositions obtained, the antiperspirant effect, the deodorizing effect, the non-whitening of the skin, the non-stickiness of the skin, and the non-toughness of the skin, as follows: The no irritation to the skin and the stability of the formulation were evaluated. The results are shown in Tables 1 to 10.
  • Formulation stability (freeze and rehydrate stability) 40 g of each of the prepared antiperspirant compositions was filled in a 50 g capacity soft transparent glass bottle (trade name: SV-50A, manufactured by Niommen Chemical Glass Co., Ltd.) and completely frozen by storing at -20 ° C. for 1 day After that, it was left to stand at room temperature for 1 day to naturally thaw. After repeating this operation 5 times, "the stability of the preparation" as the freeze recovery stability was evaluated based on the following evaluation criteria. -Evaluation criteria of formulation stability- ⁇ : no syneresis and no separation at all ⁇ : very slight syneresis but not separation O: no syneresis but not separation ⁇ : very slight separation X: separation is observed
  • the antiperspirant composition of the present invention is excellent in the deodorizing effect and the stability of the preparation as well as the antiperspirant effect, since it is not sticky after the application of the antiperspirant composition, there is no skin firmness and skin irritation. Since whiteness of the skin can be suppressed while maintaining it, it can be applied to, for example, cosmetics, medicines, quasi-drugs, etc.
  • Antiperspirant, deodorant, antiperspirant, deodorant, etc. Can be suitably used.

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Inorganic Chemistry (AREA)
  • Cosmetics (AREA)

Abstract

Provided is an antiperspirant composition that comprises: (A) at least one type of an antiperspirant component selected from among aluminum compounds, zirconium compounds, and complexes thereof; (B) a disinfectant component; (C) at least one selected from among a triglyceride (C1), a fatty acid isoamyl (C2), and a linear alkyl-modified silicone (C3); (D1) a polyoxyethylene alkyl ether having an average ethylene-oxide addition molar number of 2-8; (D2) a polyoxyethylene alkyl ether having an average ethylene-oxide addition molar number of 10-30; and (E) water, wherein the content of component (E) is 65-90 mass%.

Description

制汗剤組成物Antiperspirant composition
 本発明は、制汗剤組成物に関する。 The present invention relates to antiperspirant compositions.
 水を溶媒とするロールオンタイプやローションタイプの制汗剤には、アルミニウム塩などの制汗成分や殺菌成分が使用される。更に、感触付与などの目的で油性成分を添加する場合には、ノニオン性界面活性剤などの乳化剤が使用されることが知られている(例えば、特許文献1参照)。
 しかしながら、このような制汗剤を肌に塗布した後、溶媒の水が揮発することにより、アルミニウム塩が肌の上で白化してしまい、制汗効果と、肌の白残りのなさとを両立することが困難であるという問題があった。
Antiperspirant ingredients such as aluminum salts and bactericidal ingredients are used in roll-on type and lotion type antiperspirants that use water as a solvent. Furthermore, when adding an oil-based component for the purpose of giving a feeling etc., it is known that emulsifiers, such as nonionic surfactant, are used (for example, refer to patent documents 1).
However, after applying such an antiperspirant to the skin, the solvent water volatilizes to cause the aluminum salt to be whitened on the skin, achieving both the antiperspirant effect and the absence of white remnant on the skin. There was a problem that it was difficult to do.
 したがって、制汗効果を維持しつつ、肌の白残りを抑制することができる制汗剤組成物の開発が強く望まれているのが現状である。 Therefore, at present, there is a strong demand for the development of an antiperspirant composition capable of suppressing the white remnant of the skin while maintaining the antiperspirant effect.
特開2013-75870号公報JP, 2013-75870, A
 本発明は、従来における前記諸問題を解決し、以下の目的を達成することを課題とする。即ち、本発明は、制汗剤組成物を塗布後に肌のべたつき、肌のつっぱり感、及び肌への刺激がなく、防臭効果及び製剤の安定性に優れると共に、制汗効果を維持しつつも肌の白残りを抑制することができる制汗剤組成物を提供することを目的とする。 An object of the present invention is to solve the above-mentioned problems in the prior art and to achieve the following objects. That is, according to the present invention, after the application of the antiperspirant composition, there is no stickiness of the skin, no firm feeling on the skin and no irritation to the skin, and the deodorant effect and the stability of the preparation are excellent while maintaining the antiperspirant effect. An object of the present invention is to provide an antiperspirant composition capable of suppressing skin whiteness.
 前記課題を解決するため本発明者が鋭意検討を重ねた結果、(A)制汗成分と、(B)殺菌成分と、(C)トリグリセリド(C1)、脂肪酸イソアミル(C2)、及び直鎖状のアルキル変性シリコーン(C3)から選択される少なくとも1種と、(D1)エチレンオキサイドの平均付加モル数が2以上8以下のポリオキシエチレンアルキルエーテルと、(D2)エチレンオキサイドの平均付加モル数が10以上30以下のポリオキシエチレンアルキルエーテルと、(E)水とを配合したところ、これら成分が相乗的に働いて、制汗剤組成物を塗布後に肌のべたつき、肌のつっぱり感、及び肌への刺激がなく、防臭効果及び製剤の安定性に優れると共に、制汗効果を維持しつつも肌の白残りを抑制することができることを知見した。 As a result of intensive investigations by the inventor to solve the above problems, (A) antiperspirant component, (B) bactericidal component, (C) triglyceride (C1), fatty acid isoamyl (C2), and linear And at least one selected from the alkyl-modified silicones (C3) and polyoxyethylene alkyl ether having an average addition mole number of (D1) ethylene oxide of 2 or more and 8 or less, and (D2) an average addition mole number of ethylene oxide of When 10 or more and 30 or less polyoxyethylene alkyl ether and (E) water are blended, these components work synergistically, and after application of the antiperspirant composition, the skin becomes sticky, skin firmness, and skin It has been found that there is no irritation to the skin, the deodorizing effect and the stability of the preparation are excellent, and the white remnant of the skin can be suppressed while maintaining the antiperspirant effect.
 本発明は、本発明者による前記知見に基づくものであり、前記課題を解決するための手段としては、以下の通りである。
 <1> (A)アルミニウム化合物、ジルコニウム化合物、及びこれらの錯体から選択される少なくとも1種の制汗成分と、
 (B)殺菌成分と、
 (C)トリグリセリド(C1)、脂肪酸イソアミル(C2)、及び直鎖状のアルキル変性シリコーン(C3)から選択される少なくとも1種と、
 (D1)エチレンオキサイドの平均付加モル数が2以上8以下のポリオキシエチレンアルキルエーテルと、
 (D2)エチレンオキサイドの平均付加モル数が10以上30以下のポリオキシエチレンアルキルエーテルと、
 (E)水と、を含有し、
 前記(E)成分の含有量が、65質量%~90質量%であることを特徴とする制汗剤組成物である。
 <2> 前記(C1)成分、及び前記(C2)成分を含有し、
 前記(C1)成分の含有量と、前記(C2)成分の含有量との質量比(C1/C2)が、0.5~2である前記<1>に記載の制汗剤組成物である。
 <3> 前記(A)成分が、クロルヒドロキシアルミニウムである前記<1>から<2>のいずれかに記載の制汗剤組成物である。
 <4> 前記(B)成分が、塩化セチルピリジニウム、ベンザルコニウム塩化物、及びイソプロピルメチルフェノールから選択される少なくとも1種である前記<1>から<3>のいずれかに記載の制汗剤組成物である。
 <5> 前記(C1)成分が、トリ(カプリル酸・カプリン酸)グリセリル、及びカプリル酸トリグリセリドから選択される少なくとも1種であり、
 前記(C2)成分が、ラウリン酸イソアミル、カプリン酸イソアミル、及びヤシ油脂肪酸イソアミルから選択される少なくとも1種であり、
 前記(C3)成分が、セチルジメチコン、ステアリルジメチコン、及びカプリリルメチコンから選択される少なくとも1種である前記<1>から<4>のいずれかに記載の制汗剤組成物である。
 <6> 前記(A)成分の含有量が、7質量%~20質量%であり、
 前記(B)成分の含有量が、0.1質量%~0.3質量%であり、
 前記(C1)成分を含有する場合には、前記(C1)成分の含有量が、0.8質量%~2質量%であり、
 前記(C2)成分を含有する場合には、前記(C2)成分の含有量が、0.8質量%~2質量%であり、
 前記(C3)成分を含有する場合には、前記(C3)成分の含有量が、1質量%~3質量%であり、
 前記(D1)成分の含有量が、1.5質量%~3.5質量%であり、
 前記(D2)成分の含有量が、1.5質量%~2.5質量%であり、
 前記(E)成分の含有量が、70質量%~85質量%である前記<1>から<5>のいずれかに記載の制汗剤組成物である。
 <7> 前記(D1)成分の含有量と、前記(D2)成分の含有量との質量比(D1/D2)が、0.7~2.0である前記<1>から<6>のいずれかに記載の制汗剤組成物である。
 <8> ロールオンタイプ、及びローションタイプのいずれかである前記<1>から<7>のいずれかに記載の制汗剤組成物である。
The present invention is based on the findings by the present inventors, and means for solving the problems are as follows.
<1> (A) at least one antiperspirant component selected from an aluminum compound, a zirconium compound, and a complex thereof
(B) a bactericidal component,
(C) at least one selected from triglyceride (C1), fatty acid isoamyl (C2), and linear alkyl-modified silicone (C3);
(D1) polyoxyethylene alkyl ether having an average addition mole number of ethylene oxide of 2 or more and 8 or less,
(D2) polyoxyethylene alkyl ether having an average added mole number of ethylene oxide of 10 or more and 30 or less,
(E) containing water,
The content of the component (E) is 65% by mass to 90% by mass.
<2> The component (C1) and the component (C2) are contained,
It is an antiperspirant composition as described in said <1> whose mass ratio (C1 / C2) of content of said (C1) component and content of said (C2) component is 0.5-2 .
<3> The antiperspirant composition according to any one of <1> to <2>, wherein the component (A) is chlorhydroxyaluminum.
<4> The antiperspirant according to any one of <1> to <3>, wherein the component (B) is at least one selected from cetyl pyridinium chloride, benzalkonium chloride, and isopropyl methyl phenol It is a composition.
<5> The component (C1) is at least one selected from tri (caprylic acid / capric acid) glyceryl and caprylic acid triglyceride,
The component (C2) is at least one selected from isoamyl laurate, isoamyl caprate, and coconut oil fatty acid isoamyl;
The antiperspirant composition according to any one of <1> to <4>, wherein the component (C3) is at least one selected from cetyl dimethicone, stearyl dimethicone, and caprylyl methicone.
<6> The content of the component (A) is 7% by mass to 20% by mass,
The content of the component (B) is 0.1% by mass to 0.3% by mass,
When the component (C1) is contained, the content of the component (C1) is 0.8% by mass to 2% by mass,
When the component (C2) is contained, the content of the component (C2) is 0.8% by mass to 2% by mass,
When the component (C3) is contained, the content of the component (C3) is 1% by mass to 3% by mass,
The content of the component (D1) is 1.5% by mass to 3.5% by mass,
The content of the component (D2) is 1.5% by mass to 2.5% by mass,
The antiperspirant composition according to any one of <1> to <5>, wherein a content of the component (E) is 70% by mass to 85% by mass.
The mass ratio (D1 / D2) of the content of the <7> component (D1) to the content of the component (D2) is 0.7 to 2.0, and the mass ratio of <1> to <6> It is an antiperspirant composition in any one.
It is an antiperspirant composition in any one of said <1> to <7> which is either <8> roll-on type and a lotion type.
 本発明によると、従来における前記諸問題を解決し、前記目的を達成することができ、制汗剤組成物を塗布後に肌のべたつき、肌のつっぱり感、及び肌への刺激がなく、防臭効果及び製剤の安定性に優れると共に、制汗効果を維持しつつも肌の白残りを抑制することができる制汗剤組成物を提供することができる。 According to the present invention, the above-mentioned various problems in the prior art can be solved and the above object can be achieved, and there is no stickiness of the skin after application of the antiperspirant composition, no feeling of skin tightness and skin irritation, deodorizing effect And while being excellent in the stability of a formulation, the antiperspirant composition which can suppress the white remnant of skin can be provided, maintaining an antiperspirant effect.
(制汗剤組成物)
 本発明の制汗剤組成物は、(A)制汗成分、(B)殺菌成分、(C)トリグリセリド(C1)、脂肪酸イソアミル(C2)、及び直鎖状のアルキル変性シリコーン(C3)から選択される少なくとも1種、(D1)エチレンオキサイドの平均付加モル数が2以上8以下のポリオキシエチレンアルキルエーテル、(D2)エチレンオキサイドの平均付加モル数が10以上30以下のポリオキシエチレンアルキルエーテル、並びに(E)水を含有し、更に必要に応じてその他の成分を含有する。
(Antiperspirant composition)
The antiperspirant composition of the present invention is selected from (A) antiperspirant component, (B) bactericidal component, (C) triglyceride (C1), fatty acid isoamyl (C2), and linear alkyl-modified silicone (C3) (D1) polyoxyethylene alkyl ether having an average addition mole number of 2 or more and 8 or less, (D2) polyoxyethylene alkyl ether having an average addition mole number of 10 to 30 of (D1) ethylene oxide, And (E) contains water, and further contains other components as required.
<(A)制汗成分>
 前記(A)成分の制汗成分は、アルミニウム化合物、ジルコニウム化合物、及びこれらの錯体から選択される少なくとも1種である。
 前記(A)成分の制汗成分は、制汗効果を付与するために含有される。
<(A) Antiperspirant component>
The antiperspirant component of the component (A) is at least one selected from an aluminum compound, a zirconium compound, and a complex thereof.
The antiperspirant component of the component (A) is contained to impart an antiperspirant effect.
 前記アルミニウム化合物、ジルコニウム化合物、及びこれらの錯体としては、例えば、塩化アルミニウム、硫酸アルミニウム、硫酸アルミニウムカリウム、酢酸アルミニウム、クロルヒドロキシアルミニウム、アラントインクロルヒドロキシアルミニウム、クロルヒドロキシアルミニウム・プロピレングリコール錯体、クロルヒドロキシアルミニウム/ジルコニウム・グリシン錯体などが挙げられる。これらは、1種単独で使用してもよいし、2種以上を併用してもよい。
 これらの中でも、制汗効果がより優れる点で、クロルヒドロキシアルミニウム、クロルヒドロキシアルミニウム・プロピレングリコール錯体が好ましく、クロルヒドロキシアルミニウムがより好ましい。
Examples of the aluminum compound, zirconium compound, and complexes thereof include aluminum chloride, aluminum sulfate, aluminum potassium sulfate, aluminum acetate, chlorohydroxyaluminum, allantoin chlorohydroxyaluminum, chlorohydroxyaluminum / propylene glycol complex, chlorohydroxyaluminum / Examples thereof include zirconium and glycine complexes. These may be used alone or in combination of two or more.
Among these, chlorohydroxyaluminum and chlorohydroxyaluminum / propylene glycol complex are preferable, and chlorohydroxyaluminum is more preferable, in that the antiperspirant effect is more excellent.
 前記(A)成分の制汗成分としては、特に制限はなく、適宜作製したものを使用してもよいし、市販品を使用してもよい。前記市販品としては、例えば、クロルヒドロキシアルミニウム(商品名:クロルヒドロキシアルミニウム、多木化学株式会社製)、クロルヒドロキシアルミニウム・プロピレングリコール錯体(商品名:REHYDROL II、Summit Reheis社製)、硫酸アルミニウムカリウム(商品名:カリミョウバン、大明化学工業株式会社製)、クロルヒドロキシアルミニウム/ジルコニウム・グリシン錯体(商品名:Reach AZO-956G、Summit Reheis社製)などが挙げられる。 There is no restriction | limiting in particular as an antiperspirant component of said (A) component, What was produced suitably may be used and you may use a commercial item. Examples of the commercially available products include chlorhydroxyaluminum (trade name: chlorhydroxyaluminum, manufactured by Takaki Chemical Co., Ltd.), chlorhydroxyaluminum / propylene glycol complex (trade name: REHYDROL II, manufactured by Summit Reheis), and aluminum potassium sulfate (Trade name: potassium alum, manufactured by Daimei Chemical Industries, Ltd.), chlorhydroxyaluminum / zirconium-glycine complex (trade name: Reach AZO-956G, manufactured by Summit Reheis), and the like.
 前記(A)成分の制汗成分の含有量としては、制汗効果、肌のつっぱり感のなさ、及び肌のべたつきのなさの点から、制汗剤組成物全量に対して、5質量%~25質量%が好ましく、7質量%~20質量%がより好ましい。前記含有量が、5質量%未満であると、制汗効果が不十分となることがあり、25質量%を超えると、肌のつっぱり感のなさ、及び肌のべたつきのなさが不十分となることがある。 The content of the antiperspirant component of the component (A) is 5% by mass with respect to the total amount of the antiperspirant composition from the viewpoint of antiperspirant effect, lack of skin firmness and non-stickiness of the skin 25% by mass is preferable, and 7% by mass to 20% by mass is more preferable. When the content is less than 5% by mass, the antiperspirant effect may be insufficient, and when it exceeds 25% by mass, the feeling of skin firmness and the feeling of stickiness of the skin become insufficient. Sometimes.
<(B)殺菌成分>
 前記(B)成分の殺菌成分は、防臭効果を付与するために含有される。
<(B) sterilizing ingredient>
The sterilizing component of the component (B) is contained to impart a deodorizing effect.
 前記(B)成分の殺菌成分としては、例えば、塩化セチルピリジニウム、ベンザルコニウム塩化物、イソプロピルメチルフェノールなどが挙げられる。これらは、1種単独で使用してもよく、2種以上を併用してもよい。これらの中でも、防臭効果の点から、塩化セチルピリジニウム、ベンザルコニウム塩化物が好ましい。
 前記(B)成分の殺菌成分の市販品としては、例えば、塩化セチルピリジニウム(商品名:塩化セチルピリジニウム、和光純薬工業株式会社製)、ベンザルコニウム塩化物(商品名:トリゾン液、山田製薬株式会社製)、イソプロピルメチルフェノール(商品名:イソプロピルメチルフェノール、大阪化成株式会社製)などが挙げられる。
Examples of the sterilizing component of the component (B) include cetyl pyridinium chloride, benzalkonium chloride, isopropyl methyl phenol and the like. These may be used alone or in combination of two or more. Among these, cetyl pyridinium chloride and benzalkonium chloride are preferable in terms of the deodorizing effect.
As a commercial item of the sterilizing component of the component (B), for example, cetyl pyridinium chloride (trade name: cetyl pyridinium chloride, manufactured by Wako Pure Chemical Industries, Ltd.), benzalkonium chloride (trade name: trizone solution, Yamada Pharmaceutical Co., Ltd.) And Isopropylmethylphenol (trade name: isopropylmethylphenol, manufactured by Osaka Kasei Co., Ltd.).
 前記(B)成分の含有量としては、防臭効果、及び肌への刺激のなさの点から、制汗剤組成物全量に対して、0.05質量%~0.5質量%が好ましく、0.1質量%~0.3質量%がより好ましい。前記含有量が、0.05質量%未満であると、防臭効果が不十分となることがあり、0.5質量%を超えると、肌への刺激のなさが不十分となることがある。 The content of the component (B) is preferably 0.05% by mass to 0.5% by mass, based on the total amount of the antiperspirant composition, from the viewpoint of deodorizing effect and no irritation to the skin. 1% by mass to 0.3% by mass is more preferable. If the content is less than 0.05% by mass, the deodorizing effect may be insufficient. If the content is more than 0.5% by mass, the lack of skin irritation may be insufficient.
<(C)トリグリセリド(C1)、脂肪酸イソアミル(C2)、及び直鎖状のアルキル変性シリコーン(C3)から選択される少なくとも1種>
 前記(C)成分のトリグリセリド(C1)、脂肪酸イソアミル(C2)、及び直鎖状のアルキル変性シリコーン(C3)から選択される少なくとも1種は、肌の白残りのなさを付与するために含有される。
 前記(C)成分は、前記(C1)成分と、前記(C2)成分とを併用することが好ましい。
<(C) At least one selected from triglyceride (C1), fatty acid isoamyl (C2), and linear alkyl-modified silicone (C3)>
Component (C): at least one selected from triglyceride (C1), fatty acid isoamyl (C2), and linear alkyl-modified silicone (C3) is included to impart whiteness of the skin Ru.
It is preferable that the said (C) component uses together the said (C1) component and the said (C2) component.
 前記(C1)成分のトリグリセリドとしては、例えば、トリ(カプリル酸・カプリン酸)グリセリル、カプリル酸トリグリセリドなどが挙げられる。これらは、1種単独で使用してもよく、2種以上を併用してもよい。これらの中でも、肌の白残りのなさの点から、トリ(カプリル酸・カプリン酸)グリセリルが好ましい。 Examples of the triglyceride of the component (C1) include glyceryl tri (caprylic acid · capric acid), caprylic acid triglyceride and the like. These may be used alone or in combination of two or more. Among these, tri (caprylic acid / capric acid) glyceryl is preferable from the viewpoint of no whitening of the skin.
 前記(C2)成分の脂肪酸イソアミルとしては、例えば、ラウリン酸イソアミル、カプリル酸イソアミル、カプリン酸イソアミル、ヤシ油脂肪酸イソアミルなどが挙げられる。これらは、1種単独で使用してもよく、2種以上を併用してもよい。これらの中でも、肌の白残りのなさの点から、ラウリン酸イソアミル、カプリン酸イソアミル、ヤシ油脂肪酸イソアミルが好ましく、ラウリン酸イソアミルがより好ましい。 Examples of the fatty acid isoamyl of the component (C2) include isoamyl laurate, isoamyl caprylate, isoamyl caprate, coconut oil fatty acid isoamyl and the like. These may be used alone or in combination of two or more. Among these, isoamyl laurate, isoamyl caprate and coconut oil fatty acid isoamyl are preferable, and isoamyl laurate is more preferable, from the viewpoint of no whitening of the skin.
 前記(C3)成分の直鎖状のアルキル変性シリコーンとしては、例えば、セチルジメチコン、ステアリルジメチコン、カプリリルメチコンなどが挙げられる。これらは、1種単独で使用してもよく、2種以上を併用してもよい。これらの中でも、肌の白残りのなさの点から、セチルジメチコンが好ましい。 Examples of the linear alkyl-modified silicone of the component (C3) include cetyl dimethicone, stearyl dimethicone and caprylyl methicone. These may be used alone or in combination of two or more. Among these, cetyl dimethicone is preferable from the viewpoint of no whitening of the skin.
 前記(C1)成分の市販品としては、例えば、トリ(カプリル酸・カプリン酸)グリセリル(商品名:CRODAMOL GTCC、クローダジャパン株式会社製)、カプリル酸トリグリセリド(商品名:トリカプリリン、東京化成工業株式会社製)などが挙げられる。 Examples of commercially available products of the component (C1) include glyceryl tri (caprylic acid and capric acid) (trade name: CRODAMOL GTCC, manufactured by Croda Japan KK), caprylic acid triglyceride (trade name: tricaprylin, Tokyo Chemical Industry Co., Ltd.) Company-made).
 前記(C2)成分の市販品としては、例えば、ラウリン酸イソアミル(商品名:ラウリン酸イソアミル、東京化成工業株式会社製)、カプリル酸イソアミル(商品名:カプリル酸イソアミル、東京化成工業株式会社製)、カプリン酸イソアミル(商品名:カプリン酸イソアミル、東京化成工業株式会社製)、ヤシ油脂肪酸イソアミル(商品名:TEGOSOFT AC、Evonik Nutrition & Care GmbH社製)などが挙げられる。 Examples of commercial products of the component (C2) include isoamyl laurate (trade name: isoamyl laurate, manufactured by Tokyo Chemical Industry Co., Ltd.), and isoamyl caprylate (trade name: isoamyl caprylate, manufactured by Tokyo Chemical Industry Co., Ltd.) And isoamyl caprylate (trade name: isoamyl caprate, manufactured by Tokyo Chemical Industry Co., Ltd.), coconut oil fatty acid isoamyl (trade name: TEGOSOFT AC, manufactured by Evonik Nutrition & Care GmbH), and the like.
 前記(C3)成分の市販品としては、例えば、セチルジメチコン(商品名:ABIL WAX 9801、Evonik Nutrition & Care GmbH社製)、ステアリルジメチコン(商品名:ABIL WAX 9800、Evonik Nutrition & Care GmbH社製)、カプリリルメチコン(商品名:FZ-3196、東レ・ダウコーニング株式会社製)などが挙げられる。 Examples of commercial products of the component (C3) include cetyl dimethicone (trade name: ABIL WAX 9801, manufactured by Evonik Nutrition & Care GmbH), stearyl dimethicone (trade name: ABIL WAX 9800, manufactured by Evonik Nutrition & Care GmbH) And caprylyl methicone (trade name: FZ-3196, manufactured by Toray Dow Corning Co., Ltd.).
 前記(C1)成分の含有量としては、肌の白残りのなさ、製剤の安定性、及び肌のべたつきのなさの点から、制汗剤組成物全量に対して、0.5質量%~3質量%が好ましく、0.8質量%~2質量%がより好ましい。前記含有量が、0.5質量%未満であると、肌の白残りのなさが不十分となることがあり、3質量%を超えると、製剤の安定性、及び肌のべたつきのなさが不十分となることがある。 The content of the component (C1) is 0.5% by mass to 3% with respect to the total amount of the antiperspirant composition from the viewpoint of no whitening of the skin, stability of the preparation, and no stickiness of the skin. % By mass is preferable, and 0.8% by mass to 2% by mass is more preferable. When the content is less than 0.5% by mass, the lack of whiteness of the skin may be insufficient, and when it exceeds 3% by mass, the stability of the preparation and the non-stickiness of the skin may not be sufficient. It may be enough.
 前記(C2)成分の含有量としては、肌の白残りのなさ、製剤の安定性、及び肌のべたつきのなさの点から、制汗剤組成物全量に対して、0.5質量%~3質量%が好ましく、0.8質量%~2質量%がより好ましい。前記含有量が、0.5質量%未満であると、肌の白残りのなさが不十分となることがあり、3質量%を超えると、製剤の安定性、及び肌のべたつきのなさが不十分となることがある。 The content of the component (C2) is 0.5% by mass to 3% with respect to the total amount of the antiperspirant composition from the viewpoint of no whitening of the skin, stability of the preparation, and no stickiness of the skin. % By mass is preferable, and 0.8% by mass to 2% by mass is more preferable. When the content is less than 0.5% by mass, the lack of whiteness of the skin may be insufficient, and when it exceeds 3% by mass, the stability of the preparation and the non-stickiness of the skin may not be sufficient. It may be enough.
 前記(C3)成分の含有量としては、肌の白残りのなさ、及び製剤の安定性の点から、制汗剤組成物全量に対して、0.5質量%~5質量%が好ましく、1質量%~3質量%がより好ましい。前記含有量が、0.5質量%未満であると、肌の白残りのなさが不十分となることがあり、5質量%を超えると、製剤の安定性が不十分となることがある。 The content of the component (C3) is preferably 0.5% by mass to 5% by mass, based on the total amount of the antiperspirant composition, from the viewpoint of no whitening of the skin and the stability of the preparation. % To 3% by mass is more preferable. When the content is less than 0.5% by mass, the lack of whiteness of the skin may be insufficient, and when it exceeds 5% by mass, the stability of the preparation may be insufficient.
 前記(C1)成分の含有量と、前記(C2)成分の含有量との質量比(C1/C2)としては、製剤の安定性、及び肌のべたつきのなさの点から、0.3~3.6が好ましく、0.5~2がより好ましい。前記質量比が、0.3未満又は3.6を超えると、製剤の安定性、及び肌のべたつきのなさが不十分となることがある。 The mass ratio (C1 / C2) of the content of the component (C1) to the content of the component (C2) is 0.3 to 3 in view of the stability of the preparation and no stickiness of the skin. 6 is preferable, and 0.5 to 2 is more preferable. When the mass ratio is less than 0.3 or more than 3.6, the stability of the preparation and the tackiness of the skin may be insufficient.
<(D)ポリオキシエチレンアルキルエーテル>
 前記(D)成分のポリオキシエチレンアルキルエーテルは、(D1)エチレンオキサイドの平均付加モル数が2以上8以下のポリオキシエチレンアルキルエーテル、及び(D2)エチレンオキサイドの平均付加モル数が10以上30以下のポリオキシエチレンアルキルエーテルを含有する。
 前記(D)成分は、製剤の安定性を向上させるために含有される。
<(D) polyoxyethylene alkyl ether>
The polyoxyethylene alkyl ether of the component (D) has an average addition mole number of (D1) ethylene oxide of 2 or more and 8 or less, and an average addition mole number of (D2) ethylene oxide of 10 or more and 30. The following polyoxyethylene alkyl ether is contained.
The component (D) is included to improve the stability of the preparation.
 前記(D1)成分のエチレンオキサイドの平均付加モル数が2以上8以下のポリオキシエチレンアルキルエーテルの平均付加モル数としては、製剤の安定性の点から、2以上5未満が好ましい。前記平均付加モル数が8を超えると、製剤の安定性が不十分となることがある。
 なお、エチレンオキサイドの平均付加モル数が2未満のポリオキシエチレンアルキルエーテルについては、利用可能な市販品が存在しない。
The average addition mole number of the polyoxyethylene alkyl ether having an average addition mole number of 2 to 8 of ethylene oxide of the component (D1) is preferably 2 to less than 5 from the viewpoint of the stability of the preparation. When the average addition mole number exceeds 8, the stability of the preparation may be insufficient.
There is no commercially available product available for polyoxyethylene alkyl ethers in which the average addition mole number of ethylene oxide is less than 2.
 前記(D2)成分のエチレンオキサイドの平均付加モル数が10以上30以下のポリオキシエチレンアルキルエーテルの平均付加モル数としては、製剤の安定性、及び肌のべたつきのなさの点から、15以上25以下が好ましい。前記平均付加モル数が10未満であると、製剤の安定性が不十分となることがあり、前記平均付加モル数が30を超えると、製剤の安定性、及び肌のべたつきのなさが不十分となることがある。 The average addition mole number of the ethylene oxide in the component (D2) is 10 to 30 and the average addition mole number of the polyoxyethylene alkyl ether is 10 to 30 from the viewpoint of stability of the preparation and no stickiness of the skin. The following are preferred. When the average addition mole number is less than 10, the stability of the preparation may be insufficient, and when the average addition mole number exceeds 30, the stability of the preparation and the non-greasy skin are insufficient. It can be
 前記(D1)成分のエチレンオキサイドの平均付加モル数が2以上8以下のポリオキシエチレンアルキルエーテルとしては、特に制限はなく、目的に応じて適宜選択することができ、例えば、エチレンオキサイドの平均付加モル数が2以上8以下のポリオキシエチレンステアリルエーテルなどが挙げられる。 The polyoxyethylene alkyl ether having an average addition mole number of ethylene oxide of 2 to 8 as the component (D1) is not particularly limited and may be appropriately selected according to the purpose. For example, the average addition of ethylene oxide is The polyoxyethylene stearyl ether etc. whose number-of-moles are 2 or more and 8 or less are mentioned.
 前記(D2)成分のエチレンオキサイドの平均付加モル数が10以上30以下のポリオキシエチレンアルキルエーテルとしては、特に制限はなく、目的に応じて適宜選択することができ、例えば、エチレンオキサイドの平均付加モル数が10以上30以下のポリオキシエチレンステアリルエーテルなどが挙げられる。 There is no restriction | limiting in particular as polyoxyethylene alkylether in which the average added mole number of the ethylene oxide of the said (D2) component is 10-30, can be selected suitably according to the objective, For example, the average addition of ethylene oxide The polyoxyethylene stearyl ether etc. whose mole number is ten or more and 30 or less are mentioned.
 前記(D1)成分の市販品としては、例えば、エチレンオキサイドの平均付加モル数がそれぞれ2、3、5、及び8である、ステアレス-2(商品名:EMALEX602)、ステアレス-3(商品名:EMALEX603)、ステアレス-5(商品名:EMALEX605)、ステアレス-8(商品名:EMALEX608)(いずれも、日本エマルジョン株式会社製)などが挙げられる。 As a commercial item of the component (D1), for example, Steareth-2 (trade name: EMALEX 602) and Steareth-3 (trade name: EMALEX 603), Steareth-5 (trade name: EMALEX 605), Steareth-8 (trade name: EMALEX 608) (all manufactured by Nippon Emulsion Co., Ltd.), and the like.
 前記(D2)成分の市販品としては、例えば、エチレンオキサイドの平均付加モル数がそれぞれ11、15、16、20、25、及び30である、ステアレス-11(商品名:EMALEX611)、ステアレス-15(商品名:EMALEX615)、ステアレス-16(商品名:EMALEX616)、ステアレス-20(商品名:EMALEX620)、ステアレス-25(商品名:EMALEX625)、ステアレス-30(商品名:EMALEX630)(いずれも、日本エマルジョン株式会社製)などが挙げられる。 As a commercial item of the component (D2), for example, Steareth-11 (trade name: EMALEX 611) and Steareth-15, wherein the average addition mole number of ethylene oxide is 11, 15, 16, 20, 25 and 30, respectively. (Trade name: EMALEX 615), Steareth-16 (trade name: EMALEX 616), Steareth -20 (trade name: EMALEX 620), Steareth-25 (trade name: EMALEX 625), Steareth-30 (trade name: EMALEX 630) (all of which are Nippon Emulsion Co., Ltd.) and the like.
 前記(D1)成分の含有量としては、製剤の安定性、及び肌のべたつきのなさの点から、制汗剤組成物全量に対して、1質量%~5質量%が好ましく、1.5質量%~3.5質量%がより好ましい。前記含有量が、1質量%未満であると、製剤の安定性が不十分となることがあり、5質量%を超えると、肌のべたつきのなさが不十分となることがある。 The content of the component (D1) is preferably 1% by mass to 5% by mass, and preferably 1.5% by mass, with respect to the total amount of the antiperspirant composition, in terms of stability of the preparation and no stickiness of the skin. % To 3.5% by mass is more preferable. If the content is less than 1% by mass, the stability of the preparation may be insufficient. If it is more than 5% by mass, the tackiness of the skin may be insufficient.
 前記(D2)成分の含有量としては、製剤の安定性、及び肌のべたつきのなさの点から、制汗剤組成物全量に対して、1質量%~3質量%が好ましく、1.5質量%~2.5質量%がより好ましい。前記含有量が、1質量%未満であると、製剤の安定性が不十分となることがあり、3質量%を超えると、肌のべたつきのなさが不十分となることがある。 The content of the component (D2) is preferably 1% by mass to 3% by mass, and preferably 1.5% by mass, with respect to the total amount of the antiperspirant composition, from the viewpoint of stability of the preparation and tackiness of the skin. % To 2.5% by mass is more preferable. If the content is less than 1% by mass, the stability of the preparation may be insufficient, and if it is more than 3% by mass, the skin tackiness may be insufficient.
 前記(D1)成分の含有量と、前記(D2)成分の含有量との質量比(D1/D2)としては、製剤の安定性の点から、0.4~4.0が好ましく、0.7~2.0がより好ましい。前記質量比が、0.4未満又は4.0を超えると、製剤の安定性が不十分となることがある。 The mass ratio (D1 / D2) of the content of the component (D1) to the content of the component (D2) is preferably 0.4 to 4.0 from the viewpoint of the stability of the preparation, and 0. 7 to 2.0 is more preferable. If the mass ratio is less than 0.4 or more than 4.0, the stability of the preparation may be insufficient.
<(E)水>
 前記(E)成分の水は、製剤の安定性を付与するために含有される。
 前記(E)成分の水の含有量としては、製剤の安定性、及び肌のべたつきのなさの点から、制汗剤組成物全量に対して、65質量%~90質量%であり、70質量%~85質量%が好ましい。前記含有量が、65質量%未満であると、製剤の安定性が不十分となることがあり、90質量%を超えると、肌のべたつきのなさが不十分となることがある。
 ここで、前記(E)成分の水の含有量は、前記(A)~前記(D)成分、及びその他の成分を配合した場合、これらの成分から持ち込まれる水を含む、合計含有量である。
<(E) Water>
The water of the component (E) is contained to impart stability of the preparation.
The content of water of the component (E) is 65% by mass to 90% by mass with respect to the total amount of the antiperspirant composition from the viewpoint of stability of the preparation and no stickiness of the skin, 70% by mass % To 85% by mass is preferable. When the content is less than 65% by mass, the stability of the preparation may be insufficient, and when it is more than 90% by mass, the smoothness of the skin may be insufficient.
Here, the content of water of the component (E) is the total content including the water carried from these components when the components (A) to (D) and the other components are blended. .
<その他の成分>
 本発明の制汗剤組成物には、前記(A)~前記(E)成分以外にも、本発明の効果を損なわない範囲で、剤型に応じて、通常、制汗剤組成物に配合されるその他の成分を添加することができる。
 前記その他の成分としては、特に制限はなく、目的に応じて適宜選択することができ、例えば、油脂化合物、ワックス化合物、シリコーン化合物、炭化水素油、高級脂肪酸、高級アルコール、前記(D)成分以外の界面活性剤、ポリマー、酸化防止剤、色素、乳化安定剤、調整剤、防腐剤、紫外線吸収剤、キレート剤、保湿剤、増粘剤、清涼剤、抗炎症剤、前記(B)成分以外の殺菌剤、アミノ酸、ビタミン剤、香料、各種植物抽出エキスなどが挙げられる。
 なお、前記その他の成分の含有量としては、特に制限はなく、本発明の効果を妨げない範囲で目的に応じて適宜選択することができる。
<Other ingredients>
In addition to the components (A) to (E), the antiperspirant composition of the present invention is usually added to the antiperspirant composition according to the dosage form as long as the effects of the present invention are not impaired. Other ingredients can be added.
There is no restriction | limiting in particular as said other component, According to the objective, it can select suitably, For example, a fats-and-oils compound, a wax compound, a silicone compound, hydrocarbon oil, a higher fatty acid, a higher alcohol, except the said (D) component Surfactants, polymers, antioxidants, dyes, emulsion stabilizers, regulators, preservatives, UV absorbers, chelating agents, moisturizers, thickeners, fresheners, anti-inflammatory agents, other than the above component (B) Fungicides, amino acids, vitamins, flavors, various plant extracts and the like.
In addition, there is no restriction | limiting in particular as content of said other component, According to the objective, it can select suitably in the range which does not prevent the effect of this invention.
-pH-
 前記制汗剤組成物の25℃におけるpHとしては、制汗効果、肌への刺激のなさ、及び製剤の安定性の点から、3~4.5が好ましい。前記pHが、3未満であると、制汗効果、及び肌への刺激のなさが不十分となることがあり、4.5を超えると、製剤の安定性が不十分となることがある。
-PH-
The pH of the antiperspirant composition at 25 ° C. is preferably 3 to 4.5 from the viewpoint of antiperspirant effect, no irritation to the skin and stability of the preparation. If the pH is less than 3, the antiperspirant effect and the lack of skin irritation may be insufficient, and if it exceeds 4.5, the stability of the preparation may be insufficient.
-粘度-
 前記制汗剤組成物の粘度としては、特に制限はなく、目的に応じて適宜選択することができるが、製剤の安定性、及び肌のべたつきのなさの点から、25℃で、1mPa・s~3,000mPa・sが好ましく、5mPa・s~1,600mPa・sがより好ましい。前記粘度が、1mPa・s未満であると、製剤の安定性が不十分となることがあり、3,000mPa・sを超えると、肌のべたつきのなさが不十分となることがある。
 前記粘度は、例えば、BL型粘度計を用いて、25℃でNo.1~4のローターを使用し、60rpmで1分間の条件で測定することができる。
-viscosity-
There is no restriction | limiting in particular as a viscosity of the said antiperspirant composition, Although it can select suitably according to the objective, It is 1 mPa * s at 25 degreeC from the point of stability of a formulation, and no stickiness of skin. -3,000 mPa · s is preferable, and 5 mPa · s to 1,600 mPa · s is more preferable. When the viscosity is less than 1 mPa · s, the stability of the preparation may be insufficient, and when it is more than 3,000 mPa · s, the tackiness of the skin may be insufficient.
The viscosity is measured, for example, at 25 ° C. using a BL viscometer at 25 ° C. It can be measured at 60 rpm for 1 minute using 1 to 4 rotors.
-製造方法-
 本発明の制汗剤組成物の製造方法としては、特に制限はなく、目的に応じて適宜選択することができ、その剤型に応じて調製することができる。例えば、前記(C)成分、及び前記(D)成分を含む油相と、前記(E)成分を含む水相とを、前記(D)成分の融点以上の温度条件下で混合して乳化物を調製し、その後、必要に応じて、得られた乳化物に前記(A)成分、及び前記(B)成分を添加して混合することにより製造することができる。
 前記制汗剤組成物を調製する装置としては、特に制限はなく、目的に応じて適宜選択することができ、例えば、剪断と全体混合できる複数の撹拌羽根(プロペラ、タービン、ディスパー等)を備えた撹拌装置などが挙げられる。なお、前記(A)~前記(E)成分、及び前記その他の成分としては、制汗剤組成物を調製するにあたり、それぞれ単独で使用してもよく、また、2種以上の成分を含む混合物の状態で使用してもよい。
-Production method-
There is no restriction | limiting in particular as a manufacturing method of the antiperspirant composition of this invention, According to the objective, it can select suitably, According to the dosage form, it can prepare. For example, an emulsion is obtained by mixing an oil phase containing the component (C) and the component (D) with an aqueous phase containing the component (E) under the temperature condition equal to or higher than the melting point of the component (D) And then, if necessary, by adding and mixing the (A) component and the (B) component to the obtained emulsion.
There is no restriction | limiting in particular as an apparatus which prepares the said antiperspirant composition, According to the objective, it can select suitably, For example, it is equipped with several stirring blade (a propeller, a turbine, a disper, etc.) which can carry out whole mixing with shear. Stirring apparatus etc. are mentioned. In the preparation of the antiperspirant composition, the components (A) to (E) and the other components may be used alone or as a mixture containing two or more components. You may use it in the state of.
-剤型-
 前記制汗剤組成物の剤型としては、特に制限はなく、例えば、半固形状タイプ、ジェル状タイプ、液状タイプなどが挙げられる。これらの中でも、水分に溶解した状態で肌に塗布されることが効果発現に有効であり、高密着に塗布でき、高い制汗効果が発現できる点から、ジェル状タイプ、液状タイプが好ましく、液状タイプがより好ましい。
 前記半固形状タイプとしては、例えば、クリームタイプなどが挙げられる。
 前記ジェル状タイプとしては、例えば、ジェルタイプなどが挙げられる。
 前記液状タイプとしては、例えば、ロールオンタイプ、ローションタイプ、ミストタイプなどが挙げられる。これらの中でも、制汗効果の点から、ロールオンタイプ、ローションタイプが好ましい。
-Dosage form-
There is no restriction | limiting in particular as a dosage form of the said antiperspirant composition, For example, semi-solid type, gel-like type, liquid type etc. are mentioned. Among them, gel-type and liquid-type are preferable in that they are applied to the skin in a state dissolved in water, which is effective for exhibiting the effect, can be applied in high adhesion, and can exhibit high antiperspirant effect. Type is more preferred.
As said semi-solid type, a cream type etc. are mentioned, for example.
As said gel-like type, gel type etc. are mentioned, for example.
As said liquid type, a roll on type, a lotion type, a mist type etc. are mentioned, for example. Among these, roll-on type and lotion type are preferable in terms of antiperspirant effect.
 前記制汗剤組成物をロールオンタイプとする場合は、前記制汗剤組成物と、塗布ボールとを有し、前記制汗剤組成物を充填したロールオン容器からなる制汗剤製品とすることが好ましい。前記ロールオンタイプの製剤は、公知のロールオン容器に収容され、前記ロールオン容器にその一部が露出した状態で、かつ回転可能にホルダーで保持された前記塗布ボールに制汗剤組成物を付着させ、使用時に前記塗布ボールを肌に付着させて塗布することができる。
 また、前記制汗剤組成物をボトル容器に充填し、容器を用いてそのまま塗布するジェル製剤;指先や手を使用して塗布するジェル製剤、ローション製剤も好適に用いることができる。
When the antiperspirant composition is a roll-on type, the antiperspirant product comprises the antiperspirant composition and a coating ball, and comprises a roll-on container filled with the antiperspirant composition. preferable. The roll-on type preparation is contained in a known roll-on container, and the antiperspirant composition is attached to the coating ball held in a holder rotatably with a part thereof exposed in the roll-on container, The application ball can be attached to the skin and applied at the time of use.
Further, a gel preparation which is filled with the antiperspirant composition in a bottle container and applied as it is using a container; a gel preparation which is applied using a fingertip or a hand, and a lotion preparation can also be suitably used.
-容器-
 前記容器としては、例えば、ロールオン容器、ジェル用ボトル容器、ローション用ボトル容器、ミスト用トリガー型スプレー容器などが挙げられる。これらの中でも、制汗効果の点から、ロールオン容器が好ましい。
 前記ロールオン容器は、前記制汗剤組成物を肌に高密着に塗布でき、制汗効果を発現できる点で好適に使用できる。前記ロールオン容器としては、前記制汗剤組成物を充填できるものであれば特に制限はなく、目的に応じて適宜選択することができ、例えば、特開2005-186997号公報に記載されたものなどが挙げられる。
-container-
Examples of the container include a roll-on container, a bottle container for gel, a bottle container for lotion, and a trigger type spray container for mist. Among these, roll-on containers are preferable in terms of antiperspirant effect.
The roll-on container can be suitably used in that the antiperspirant composition can be applied in close contact with the skin and the antiperspirant effect can be exhibited. The roll-on container is not particularly limited as long as it can be filled with the antiperspirant composition, and can be appropriately selected according to the purpose. For example, those described in JP-A-2005-186997 and the like Can be mentioned.
 前記ロールオン容器としては、例えば、ボトル(材質:HDPE ナチュラル、満注内容量:約56mL、胴径:約33mm、高さ:約87mm、株式会社吉野工業所製)、リング(材質:LLDPE ナチュラル、外径:約26mm、高さ:約18mm、株式会社吉野工業所製)、ボール(材質:PP ホワイト、直径:約20mm、株式会社吉野工業所製)などを使用することができる。 As the roll-on container, for example, a bottle (material: HDPE natural, full filling internal volume: about 56 mL, body diameter: about 33 mm, height: about 87 mm, made by Yoshino Kogyo Co., Ltd.), ring (material: LLDPE natural, Outer diameter: about 26 mm, height: about 18 mm, manufactured by Yoshino Industry Co., Ltd., ball (material: PP white, diameter: about 20 mm, manufactured by Yoshino Industrial Co., Ltd.), etc. can be used.
 前記ローション用ボトル容器としては、例えば、ボトル(商品名:TOMIII-50、材質:HDPE ナチュラル、満注内容量:約34mL、胴径:約42mm×29mm(オーバル)、高さ:約88mm、竹本容器株式会社製)、中栓(商品名:TO キャップ用ノズルA、材質:PE ナチュラル、外径:約12mm、高さ:約13mm、竹本容器株式会社製)、キャップ(商品名:TOMIII キャップ、材質:PP ホワイト、外径:約37mm×25mm(オーバル)、高さ:約24mm、竹本容器株式会社製)などを使用することができる。 As the bottle container for lotions, for example, a bottle (trade name: TOM III-50, material: HDPE natural, full filling volume: about 34 mL, body diameter: about 42 mm × 29 mm (oval), height: about 88 mm, Takemoto Container Co., Ltd.), inside plug (product name: TO cap nozzle A, material: PE natural, outer diameter: about 12 mm, height: about 13 mm, product made by Takemoto Container Co., Ltd.), cap (product name: TOM III cap, Material: PP white, outer diameter: about 37 mm × 25 mm (oval), height: about 24 mm, manufactured by Takemoto Container Co., Ltd.) or the like can be used.
-用途-
 本発明の制汗剤組成物は、制汗剤組成物を塗布後に肌のべたつき、肌のつっぱり感、及び肌への刺激がなく、防臭効果及び製剤の安定性に優れると共に、制汗効果を維持しつつも肌の白残りを抑制することができるため、例えば、化粧料、医薬品、医薬部外品等に適用することができ、制汗剤、防臭剤、制汗防臭剤、デオドラント剤に好適に利用可能である。
-Applications-
The antiperspirant composition of the present invention is excellent in the deodorizing effect and the stability of the preparation as well as the antiperspirant effect, since it is not sticky after the application of the antiperspirant composition, there is no skin firmness and skin irritation. As whiteness of the skin can be suppressed while maintaining it, for example, it can be applied to cosmetics, medicines, quasi-drugs, etc., and it can be used as an antiperspirant, deodorant, antiperspirant, deodorant and deodorant. It is suitably available.
 以下に本発明の実施例を挙げて本発明を具体的に説明するが、本発明はこれらの実施例に何ら限定されるものではない。なお、実施例、及び比較例の記載の各成分の含有量は、質量%で示し、全て純分換算した値である。 EXAMPLES Hereinafter, the present invention will be specifically described by way of examples of the present invention, but the present invention is not limited to these examples. In addition, content of each component of the description of an Example and a comparative example is shown by the mass%, and it is the value all converted into a pure part.
(実施例1~57、及び比較例1~10)
 下記表1~表10に示す組成からなる、実施例1~57、及び比較例1~10の制汗剤組成物を常法により調製した。
 得られた各制汗剤組成物40mLを、下記仕様のロールオン容器に充填して、ロールオンタイプの制汗剤組成物とした。
(Examples 1 to 57 and Comparative Examples 1 to 10)
The antiperspirant compositions of Examples 1 to 57 and Comparative Examples 1 to 10, which have the compositions shown in Tables 1 to 10 below, were prepared by an ordinary method.
40 mL of each obtained antiperspirant composition was filled in a roll-on container of the following specification to make a roll-on type antiperspirant composition.
<ロールオン容器>
<<ボトル>>
 ・株式会社吉野工業所製
  材質:HDPE ナチュラル、満注内容量:約56mL、胴径:約33mm、高さ:約87mm
<<リング>>
 ・株式会社吉野工業所製
  材質:LLDPE ナチュラル、外径:約26mm、高さ:約18mm
<<ボール>>
 ・株式会社吉野工業所製
  材質:PP ホワイト、直径:約20mm
<Roll-on container>
<< Bottle >>
-Made by Yoshino Kogyo Co., Ltd. Material: HDPE Natural, full fill volume: about 56 mL, body diameter: about 33 mm, height: about 87 mm
<< Ring >>
-Made by Yoshino Kogyo Co., Ltd. Material: LLDPE Natural, Outer diameter: about 26 mm, Height: about 18 mm
<< Ball >>
-Made by Yoshino Kogyo Co., Ltd. Material: PP white, diameter: about 20 mm
 次に、得られたロールオンタイプの各制汗剤組成物について、以下のようにして、制汗効果、防臭効果、肌の白残りのなさ、肌のべたつきのなさ、肌のつっぱり感のなさ、肌への刺激のなさ、及び製剤の安定性を評価した。結果を表1~表10に示す。 Next, for each of the roll-on type antiperspirant compositions obtained, the antiperspirant effect, the deodorizing effect, the non-whitening of the skin, the non-stickiness of the skin, and the non-toughness of the skin, as follows: The no irritation to the skin and the stability of the formulation were evaluated. The results are shown in Tables 1 to 10.
<制汗効果>
 専門パネル20名に対し、片側の腋窩に各制汗剤組成物(試料)を0.5g塗布し、38℃、相対湿度40%環境下においてフィットネスバイク(商品名:FB-300HP、リマーク社製)による運動を15分間行った。その後、発汗計(商品名:SKN-2000、株式会社西澤電機計器製作所製)を用いて試料を塗布した腋窩(試料塗布部)、及び試料未塗布の腋窩(試料未塗布部)の発汗量を測定し、下記式から制汗率を求めた。専門パネル20名の平均値を算出し、下記評価基準に基づいて、「制汗効果」を評価した。
Figure JPOXMLDOC01-appb-M000001
<Antiperspirant effect>
0.5 g of each antiperspirant composition (sample) is applied to the axilla on one side to 20 specialized panels, and a fitness bike (trade name: FB-300 HP, manufactured by Remark Corp.) at 38 ° C. and 40% relative humidity environment Exercise for 15 minutes. Thereafter, the amount of sweating of the axilla (sample-coated portion) to which the sample is applied using a perspiration meter (trade name: SKN-2000, manufactured by Nishizawa Denki Keiki Seisakusho Co., Ltd.) and the sample-uncoated axillary (sample uncoated portion) It measured and calculated | required the perspiration rate from the following formula. The average value of 20 specialist panels was calculated, and the "antiperspirant effect" was evaluated based on the following evaluation criteria.
Figure JPOXMLDOC01-appb-M000001
-制汗効果の評価基準-
 ◎◎:制汗率の平均値が56%以上100%以下
  ◎:制汗率の平均値が46%以上56%未満
  ○:制汗率の平均値が36%以上46%未満
  △:制汗率の平均値が26%以上36%未満
  ×:制汗率の平均値が0%以上26%未満
-Evaluation criteria for antiperspirant effect-
◎: average value of antiperspirant rate 56% to 100% ◎: average value of antiperspirant rate 46% to less than 56% ○: average value of antiperspirant rate 36% to less than 46% Δ: antiperspirant Average value of rate is 26% or more and less than 36% ×: Average value of antiperspirant rate is 0% or more and less than 26%
<防臭効果>
 専門パネル20名に対し、腋窩に各制汗剤組成物を0.5g塗布し、乾燥させた後、防臭効果がよいと回答した人数により、下記評価基準に基づいて、「防臭効果」を評価した。
-防臭効果の評価基準-
 ◎◎:専門パネル20名中19名以上20名以下が、防臭効果がよいと回答
  ◎:専門パネル20名中16名以上18名以下が、防臭効果がよいと回答
  ○:専門パネル20名中11名以上15名以下が、防臭効果がよいと回答
  △:専門パネル20名中6名以上10名以下が、防臭効果がよいと回答
  ×:専門パネル20名中5名以下が、防臭効果がよいと回答
<Deodorant effect>
After applying 0.5 g of each antiperspirant composition to the axilla and drying it for 20 specialized panels, the "deodorant effect" was evaluated based on the following evaluation criteria by the number of persons who answered that the deodorizing effect is good did.
-Evaluation criteria for deodorizing effect-
◎ 19: 19 or more 20 out of 20 specialized panelists, answer that deodorizing effect is good :: 16 or more out of 20 specialized panelers 18 or less answer, that deodorant effect is good ○: out of 20 specialized panelists 11 or more and 15 or less answered that the deodorizing effect is good :: 6 or more out of 20 professional panels and 10 or less answered that the deodorizing effect is good ×: five or less out of 20 specialized panels have the deodorizing effect Good answer
<肌の白残りのなさ>
 専門パネル20名に対し、腋窩に各制汗剤組成物を0.5g塗布し、乾燥させた後、肌の白残りがないと回答した人数により、下記評価基準に基づいて、「肌の白残りのなさ」を評価した。
-肌の白残りのなさの評価基準-
 ◎◎:専門パネル20名中19名以上20名以下が、肌の白残りがないと回答
  ◎:専門パネル20名中16名以上18名以下が、肌の白残りがないと回答
  ○:専門パネル20名中11名以上15名以下が、肌の白残りがないと回答
  △:専門パネル20名中6名以上10名以下が、肌の白残りがないと回答
  ×:専門パネル20名中5名以下が、肌の白残りがないと回答
<No white remnant of skin>
After applying 0.5 g of each antiperspirant composition to the axilla to 20 specialized panels and drying it, the number of people who answered that there is no white residual skin, based on the following evaluation criteria: I evaluated "the rest".
-Evaluation criteria for the absence of skin whiteness-
◎ 19: 19 or more 20 out of 20 specialized panels, but no white remnant of the skin 回答: 16 or more out of 20 specialized panel s 18 or less, reply if there is no white remnant of skin ○ ○: specialty 11 or more and 15 or less out of 20 panels answered that there is no white skin residue △: 6 or more out of 20 specialized panels and 10 or less people answered that there is no white skin residue ×: Out of 20 specialized panels Less than 5 people answered that there is no skin whiteness remaining
<肌のべたつきのなさ>
 専門パネル20名に対し、腋窩に各制汗剤組成物を0.5g塗布し、乾燥させた後、肌のべたつきがないと回答した人数により、下記評価基準に基づいて、制汗剤組成物塗布後の「肌のべたつきのなさ」を評価した。
-肌のべたつきのなさの評価基準-
 ◎◎:専門パネル20名中19名以上20名以下が、肌のべたつき感がないと回答
  ◎:専門パネル20名中16名以上18名以下が、肌のべたつき感がないと回答
  ○:専門パネル20名中11名以上15名以下が、肌のべたつき感がないと回答
  △:専門パネル20名中6名以上10名以下が、肌のべたつき感がないと回答
  ×:専門パネル20名中5名以下が、肌のべたつき感がないと回答
<No stickiness of the skin>
After applying 0.5 g of each antiperspirant composition to the axilla to 20 specialist panels and drying it, the number of persons who answered that there is no stickiness on the skin is based on the following evaluation criteria: The "non-stickiness of skin" after application was evaluated.
-Evaluation criteria for no stickiness of skin-
◎ 19: 19 or more and 20 or less of 20 specialized panelists, but no skin sticky feeling 回答: 16 or more and 18 out of 20 specialized panelists, non-sticky skin responses ○: specialized 11 or more and 15 or less out of 20 panels answered that there is no feeling of skin tackiness △: 6 or more out of 20 specialized panels and 10 or less people answered that there is no sticky feeling on skin ×: Out of 20 specialized panels Less than 5 people answered that there is no feeling of stickiness on the skin
<肌のつっぱり感のなさ>
 専門パネル20名に対し、腋窩に各制汗剤組成物を0.5g塗布し、乾燥させた後、肌のつっぱり感がないと回答した人数により、下記評価基準に基づいて、制汗剤組成物塗布後の「肌のつっぱり感のなさ」を評価した。
-肌のつっぱり感のなさの評価基準-
 ◎◎:専門パネル20名中19名以上20名以下が、肌のつっぱり感がないと回答
  ◎:専門パネル20名中16名以上18名以下が、肌のつっぱり感がないと回答
  ○:専門パネル20名中11名以上15名以下が、肌のつっぱり感がないと回答
  △:専門パネル20名中6名以上10名以下が、肌のつっぱり感がないと回答
  ×:専門パネル20名中5名以下が、肌のつっぱり感がないと回答
<No feeling of skin firmness>
After applying 0.5 g of each antiperspirant composition to the axilla to 20 specialized panels and drying it, the number of persons who answered that there is no feeling of skin tightness, based on the following evaluation criteria, antiperspirant composition After the application of the product, the "lack of skin firmness" was evaluated.
-Evaluation criteria for lack of skin firmness-
◎ 19: 19 or more and 20 or less of 20 specialized panels answered that there is no skin firmness :: 16 or more out of 20 specialized panels and 18 or less people answered that there is no skin pinched ○: Specialized 11 or more and 15 or less out of 20 panelists answered that there is no skin firmness feeling △: 6 or more out of 20 specialized panelists and 10 or less people answered that there is no skin tightness feeling ×: that among 20 specialized panelists Less than 5 people answered that there is no feeling of skin tension
<肌への刺激のなさ>
 専門パネル20名に対し、腋窩に各制汗剤組成物を0.5g塗布し、乾燥させた後、肌への刺激がないと回答した人数により、下記評価基準に基づいて、制汗剤組成物塗布後の「肌へ刺激のなさ」を評価した。
-肌への刺激のなさの評価基準-
 ◎◎:専門パネル20名中19名以上20名以下が、肌への刺激がないと回答
  ◎:専門パネル20名中16名以上18名以下が、肌への刺激がないと回答
  ○:専門パネル20名中11名以上15名以下が、肌への刺激がないと回答
  △:専門パネル20名中6名以上10名以下が、肌への刺激がないと回答
  ×:専門パネル20名中5名以下が、肌への刺激がないと回答
<No irritation to the skin>
After applying 0.5 g of each antiperspirant composition to the axilla to 20 specialist panels and drying it, the number of persons who answered that there was no skin irritation based on the following evaluation criteria The "non-irritating to the skin" after the object application was evaluated.
-Evaluation criteria for lack of skin irritation-
◎ :: 19 or more and 20 or less out of 20 specialized panels answered that there is no skin irritation ◎: 16 or more out of 20 specialized panels and 18 or less answered that there is no skin irritation ○: Specialized 11 or more and 15 or less out of 20 panels answered that there is no skin irritation △: 6 or more out of 20 specialized panels and 10 or less answered that there is no skin irritation ×: Out of 20 specialized panels Less than 5 people answered that there is no skin irritation
<製剤の安定性(凍結復元安定性)>
 容量50gの軟質透明ガラス瓶(商品名:SV-50A、日電理化硝子株式会社製)に、調製した各制汗剤組成物を40g充填し、-20℃に1日間保存して完全に凍結させた後、室温にて1日間放置し自然解凍した。この操作を5回繰り返した後の凍結復元安定性としての「製剤の安定性」を下記評価基準に基づいて評価した。
-製剤の安定性の評価基準-
 ◎◎:離水、及び分離が全く認められない
  ◎:ごく僅かに離水が認められるが、分離は認められない
  ○:離水が認められるが、分離は認められない
  △:ごく僅かに分離が認められる
  ×:分離が認められる
Formulation stability (freeze and rehydrate stability)
40 g of each of the prepared antiperspirant compositions was filled in a 50 g capacity soft transparent glass bottle (trade name: SV-50A, manufactured by Nichiden Chemical Glass Co., Ltd.) and completely frozen by storing at -20 ° C. for 1 day After that, it was left to stand at room temperature for 1 day to naturally thaw. After repeating this operation 5 times, "the stability of the preparation" as the freeze recovery stability was evaluated based on the following evaluation criteria.
-Evaluation criteria of formulation stability-
◎: no syneresis and no separation at all ◎: very slight syneresis but not separation O: no syneresis but not separation Δ: very slight separation X: separation is observed
Figure JPOXMLDOC01-appb-T000002
Figure JPOXMLDOC01-appb-T000002
Figure JPOXMLDOC01-appb-T000003
Figure JPOXMLDOC01-appb-T000003
Figure JPOXMLDOC01-appb-T000004
Figure JPOXMLDOC01-appb-T000004
Figure JPOXMLDOC01-appb-T000005
Figure JPOXMLDOC01-appb-T000005
Figure JPOXMLDOC01-appb-T000006
Figure JPOXMLDOC01-appb-T000006
Figure JPOXMLDOC01-appb-T000007
Figure JPOXMLDOC01-appb-T000007
Figure JPOXMLDOC01-appb-T000008
Figure JPOXMLDOC01-appb-T000008
Figure JPOXMLDOC01-appb-T000009
Figure JPOXMLDOC01-appb-T000009
Figure JPOXMLDOC01-appb-T000010
Figure JPOXMLDOC01-appb-T000010
Figure JPOXMLDOC01-appb-T000011
Figure JPOXMLDOC01-appb-T000011
(処方例1)
 下記表11に示す組成の制汗剤組成物を常法により調製し、得られた各制汗剤組成物40mLを、下記仕様のローションタイプの容器に充填して、実施例3におけるロールオンタイプの制汗剤組成物と同様の評価を実施した。結果を表11中に併記した。
(Prescription example 1)
An antiperspirant composition having the composition shown in the following Table 11 was prepared by a conventional method, and 40 mL of each of the obtained antiperspirant compositions was filled into a lotion type container of the following specification to obtain a roll-on type The same evaluation as that of the antiperspirant composition was carried out. The results are shown in Table 11.
<ローション:ボトル容器>
 充填量:40mL
<<ボトル>>
 ・竹本容器株式会社製:TOMIII-50
 材質:HDPE ナチュラル、満注内容量:約34mL、胴径:約42mm×29mm(オーバル)、高さ:約88mm
<<中栓>>
 ・竹本容器株式会社製:TO キャップ用ノズルA
 材質:PE ナチュラル、外径:約12mm、高さ:約13mm
<<キャップ>>
 ・竹本容器株式会社製:TOMIII キャップ
 材質:PP ホワイト、外径:約37mm×25mm(オーバル)、高さ:約24mm
<Lotion: Bottle container>
Filling volume: 40mL
<< Bottle >>
-Takemoto Container Co., Ltd. product: TOM III-50
Material: HDPE Natural, full fill internal volume: about 34 mL, body diameter: about 42 mm × 29 mm (oval), height: about 88 mm
<< Inside stopper >>
-Takemoto Container Co., Ltd .: TO cap nozzle A
Material: PE natural, outer diameter: about 12 mm, height: about 13 mm
<< Caps >>
-Takemoto Container Co., Ltd .: TOM III Cap Material: PP white, outer diameter: about 37 mm x 25 mm (oval), height: about 24 mm
Figure JPOXMLDOC01-appb-T000012
Figure JPOXMLDOC01-appb-T000012
 実施例、比較例、及び処方例の各成分の詳細は、下記表12に記載のとおりである。
Figure JPOXMLDOC01-appb-T000013
The details of each component of the examples, comparative examples, and formulation examples are as described in Table 12 below.
Figure JPOXMLDOC01-appb-T000013
 本発明の制汗剤組成物は、制汗剤組成物を塗布後に肌のべたつき、肌のつっぱり感、及び肌への刺激がなく、防臭効果及び製剤の安定性に優れると共に、制汗効果を維持しつつも肌の白残りを抑制することができるため、例えば、化粧料、医薬品、医薬部外品等に適用することができ、制汗剤、防臭剤、制汗防臭剤、デオドラント剤などに好適に利用可能である。 The antiperspirant composition of the present invention is excellent in the deodorizing effect and the stability of the preparation as well as the antiperspirant effect, since it is not sticky after the application of the antiperspirant composition, there is no skin firmness and skin irritation. Since whiteness of the skin can be suppressed while maintaining it, it can be applied to, for example, cosmetics, medicines, quasi-drugs, etc. Antiperspirant, deodorant, antiperspirant, deodorant, etc. Can be suitably used.

Claims (8)

  1.  (A)アルミニウム化合物、ジルコニウム化合物、及びこれらの錯体から選択される少なくとも1種の制汗成分と、
     (B)殺菌成分と、
     (C)トリグリセリド(C1)、脂肪酸イソアミル(C2)、及び直鎖状のアルキル変性シリコーン(C3)から選択される少なくとも1種と、
     (D1)エチレンオキサイドの平均付加モル数が2以上8以下のポリオキシエチレンアルキルエーテルと、
     (D2)エチレンオキサイドの平均付加モル数が10以上30以下のポリオキシエチレンアルキルエーテルと、
     (E)水と、を含有し、
     前記(E)成分の含有量が、65質量%~90質量%であることを特徴とする制汗剤組成物。
    (A) at least one antiperspirant component selected from aluminum compounds, zirconium compounds, and complexes thereof,
    (B) a bactericidal component,
    (C) at least one selected from triglyceride (C1), fatty acid isoamyl (C2), and linear alkyl-modified silicone (C3);
    (D1) polyoxyethylene alkyl ether having an average addition mole number of ethylene oxide of 2 or more and 8 or less,
    (D2) polyoxyethylene alkyl ether having an average added mole number of ethylene oxide of 10 or more and 30 or less,
    (E) containing water,
    Content of the said (E) component is 65 mass%-90 mass%, The antiperspirant composition characterized by the above-mentioned.
  2.  前記(C1)成分、及び前記(C2)成分を含有し、
     前記(C1)成分の含有量と、前記(C2)成分の含有量との質量比(C1/C2)が、0.5~2である請求項1に記載の制汗剤組成物。
    The component (C1) and the component (C2);
    The antiperspirant composition according to claim 1, wherein a mass ratio (C1 / C2) of the content of the component (C1) to the content of the component (C2) is 0.5 to 2.
  3.  前記(A)成分が、クロルヒドロキシアルミニウムである請求項1から2のいずれかに記載の制汗剤組成物。 The antiperspirant composition according to any one of claims 1 to 2, wherein the component (A) is chlorhydroxyaluminum.
  4.  前記(B)成分が、塩化セチルピリジニウム、ベンザルコニウム塩化物、及びイソプロピルメチルフェノールから選択される少なくとも1種である請求項1から3のいずれかに記載の制汗剤組成物。 The antiperspirant composition according to any one of claims 1 to 3, wherein the component (B) is at least one selected from cetyl pyridinium chloride, benzalkonium chloride, and isopropyl methyl phenol.
  5.  前記(C1)成分が、トリ(カプリル酸・カプリン酸)グリセリル、及びカプリル酸トリグリセリドから選択される少なくとも1種であり、
     前記(C2)成分が、ラウリン酸イソアミル、カプリン酸イソアミル、及びヤシ油脂肪酸イソアミルから選択される少なくとも1種であり、
     前記(C3)成分が、セチルジメチコン、ステアリルジメチコン、及びカプリリルメチコンから選択される少なくとも1種である請求項1から4のいずれかに記載の制汗剤組成物。
    The component (C1) is at least one selected from tri (caprylic acid / capric acid) glyceryl and caprylic acid triglyceride,
    The component (C2) is at least one selected from isoamyl laurate, isoamyl caprate, and coconut oil fatty acid isoamyl;
    The antiperspirant composition according to any one of claims 1 to 4, wherein the component (C3) is at least one selected from cetyl dimethicone, stearyl dimethicone, and caprylyl methicone.
  6.  前記(A)成分の含有量が、7質量%~20質量%であり、
     前記(B)成分の含有量が、0.1質量%~0.3質量%であり、
     前記(C1)成分を含有する場合には、前記(C1)成分の含有量が、0.8質量%~2質量%であり、
     前記(C2)成分を含有する場合には、前記(C2)成分の含有量が、0.8質量%~2質量%であり、
     前記(C3)成分を含有する場合には、前記(C3)成分の含有量が、1質量%~3質量%であり、
     前記(D1)成分の含有量が、1.5質量%~3.5質量%であり、
     前記(D2)成分の含有量が、1.5質量%~2.5質量%であり、
     前記(E)成分の含有量が、70質量%~85質量%である請求項1から5のいずれかに記載の制汗剤組成物。
    The content of the component (A) is 7% by mass to 20% by mass,
    The content of the component (B) is 0.1% by mass to 0.3% by mass,
    When the component (C1) is contained, the content of the component (C1) is 0.8% by mass to 2% by mass,
    When the component (C2) is contained, the content of the component (C2) is 0.8% by mass to 2% by mass,
    When the component (C3) is contained, the content of the component (C3) is 1% by mass to 3% by mass,
    The content of the component (D1) is 1.5% by mass to 3.5% by mass,
    The content of the component (D2) is 1.5% by mass to 2.5% by mass,
    The antiperspirant composition according to any one of claims 1 to 5, wherein the content of the component (E) is 70% by mass to 85% by mass.
  7.  前記(D1)成分の含有量と、前記(D2)成分の含有量との質量比(D1/D2)が、0.7~2.0である請求項1から6のいずれかに記載の制汗剤組成物。 The mass ratio (D1 / D2) of the content of the component (D1) to the content of the component (D2) is 0.7 to 2.0. Sweat composition.
  8.  ロールオンタイプ、及びローションタイプのいずれかである請求項1から7のいずれかに記載の制汗剤組成物。 The antiperspirant composition according to any one of claims 1 to 7, which is one of roll-on type and lotion type.
PCT/JP2018/031834 2017-09-21 2018-08-28 Antiperspirant composition WO2019058904A1 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
JP2017-181210 2017-09-21
JP2017181210 2017-09-21
JP2018044089A JP7049868B2 (en) 2017-09-21 2018-03-12 Antiperspirant composition
JP2018-044089 2018-03-12

Publications (1)

Publication Number Publication Date
WO2019058904A1 true WO2019058904A1 (en) 2019-03-28

Family

ID=65811369

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/JP2018/031834 WO2019058904A1 (en) 2017-09-21 2018-08-28 Antiperspirant composition

Country Status (1)

Country Link
WO (1) WO2019058904A1 (en)

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2001503039A (en) * 1996-10-19 2001-03-06 バイヤースドルフ・アクチエンゲゼルシヤフト Highly hydrated antiperspirant and / or deodorant stick
JP2009046426A (en) * 2007-08-20 2009-03-05 Shiseido Co Ltd Skin care preparation for external use
JP2012506844A (en) * 2008-10-27 2012-03-22 ユニリーバー・ナームローゼ・ベンノートシヤープ Antiperspirant or deodorant composition
JP2014503586A (en) * 2011-01-24 2014-02-13 アンテリオス, インコーポレイテッド Oil composition
US20170202770A1 (en) * 2016-01-15 2017-07-20 Evonik Degussa Gmbh Composition comprising polyglycerol esters and hydroxyalkyl-modified guar

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2001503039A (en) * 1996-10-19 2001-03-06 バイヤースドルフ・アクチエンゲゼルシヤフト Highly hydrated antiperspirant and / or deodorant stick
JP2009046426A (en) * 2007-08-20 2009-03-05 Shiseido Co Ltd Skin care preparation for external use
JP2012506844A (en) * 2008-10-27 2012-03-22 ユニリーバー・ナームローゼ・ベンノートシヤープ Antiperspirant or deodorant composition
JP2014503586A (en) * 2011-01-24 2014-02-13 アンテリオス, インコーポレイテッド Oil composition
US20170202770A1 (en) * 2016-01-15 2017-07-20 Evonik Degussa Gmbh Composition comprising polyglycerol esters and hydroxyalkyl-modified guar

Similar Documents

Publication Publication Date Title
JP3657395B2 (en) Composition for external use
MX2008001954A (en) Antiperspirant compositions.
JP6553454B2 (en) Antiperspirant composition
EP2405885A1 (en) Thickening additive compositions
JP6900122B2 (en) Antiperspirant composition and antiperspirant
WO2019058904A1 (en) Antiperspirant composition
JP7049868B2 (en) Antiperspirant composition
JP6900121B2 (en) Antiperspirant composition and antiperspirant
EP1486199A1 (en) Alcoholic aerosol deodorant composition containing zinc salicylate or a derivative thereof
JP7009088B2 (en) Antiperspirant composition
JP5951155B1 (en) Emulsified deodorant composition and deodorant agent
JP6594759B2 (en) Antiperspirant composition
JP6909179B2 (en) Oily cosmetics
JP6893485B2 (en) Cleansing cosmetics
JP3675637B2 (en) Composition for external use
JP6660258B2 (en) Antiperspirant composition
JP2021091613A (en) Oily skin protectant
JP3649619B2 (en) Composition for external use
EP0946135B1 (en) Non-aqueous antiperspirant composition
JP2022096800A (en) Antiperspirant composition
JP7101097B2 (en) Antiperspirant composition
JP7309400B2 (en) emulsified cosmetic composition
JP2013075870A (en) Emulsified antiperspirant cosmetic
JP6614071B2 (en) Liquid oral composition
JP3649620B2 (en) Composition for external use

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 18859278

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 18859278

Country of ref document: EP

Kind code of ref document: A1